A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China

While China is a major manufacturer of artemisinin and its derivatives, it lags as a global leader in terms of the total export value of anti-malarial drugs as finished pharmaceutical products ready for market...

Source: Malaria Journal - April 3, 2018 Category: Infectious Diseases Authors: Yangmu Huang, Ke Pan, Danlu Peng and Andy Stergachis Tags: Research Source Type: research